Clinical trial
A Phase 2 Study to Evaluate and Compare the Efficacy of Injections of Cultured Occipital Autologous Dermal and Epidermal Cells vs Dermal Cells, Where Cells Are Expanded ex Vivo From Plucked Scalp, Into the Hair Loss Area of the Scalp of Subjects.
NCT01451177 is registered in ClinicalTrials.gov with Aderans Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study to Evaluate and Compare the Efficacy of Injections of Cultured Occipital Autologous Dermal and Epidermal Cells vs Dermal Cells, Where Cells Are Expanded ex Vivo From Plucked Scalp, Into the Hair Loss Area of the Scalp of Subjects.
- Lead sponsor
- Aderans Research Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2010
- Completion date
- Not reported
- Enrollment
- 43 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
androgenetic alopecia, female pattern baldness, male pattern baldness